Zohre Momenimovahed
Oncology · 2019
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 16 citations into it
Whom Zohre Momenimovahed trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Zohre Momenimovahed's perspective
Ordered by how strongly the researchers Zohre Momenimovahed trusts endorse each paper. Same corpus, a different order for every researcher.
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers (Journal of the American Medical Association (JAMA))
- Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC) (International Journal of Cancer)
- Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival (Clinical Medicine Research)
- Diabetes mellitus and risk of breast cancer: A meta‐analysis (International Journal of Cancer)
- Breast cancer statistics, 2013 (Ca)
- Breast cancer statistics, 2017, racial disparity in mortality by state (Ca)
- Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. (Journal of the National Cancer Institute)
- Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study (Breast Cancer Research and Treatment)
- Global trends in breast cancer incidence and mortality 1973-1997. (International Journal of Epidemiology)
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
Their papers
- Ovarian cancer in the world: epidemiology and risk factors (2019) — 820 citations
- Epidemiological characteristics of and risk factors for breast cancer in the world (2019) — 881 citations